Cargando…

Autoantibodies against chemokines linked with better disease outcomes in COVID-19

Detalles Bibliográficos
Autor principal:	Bordon, Yvonne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	In Brief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013265/ https://www.ncbi.nlm.nih.gov/pubmed/36918666 http://dx.doi.org/10.1038/s41577-023-00860-2

Ejemplares similares

A new set of genes linked to critical COVID-19
por: Bordon, Yvonne
Publicado: (2022)

Repurposing metabolic drugs for COVID-19
por: Bordon, Yvonne
Publicado: (2023)

Comparing paediatric COVID-19 with MIS-C
por: Bordon, Yvonne
Publicado: (2022)

Hypoxia and IL-24 drive a sterile wound healing pathway
por: Bordon, Yvonne
Publicado: (2023)

Social distancing plus rapid vaccination prevents emergence of SARS-CoV-2 variants
por: Bordon, Yvonne
Publicado: (2022)

NSAIDs not linked to worse COVID-19 outcomes
por: Onuora, Sarah
Publicado: (2021)

Kawasaki disease linked to COVID-19 in children
por: Moreira, Alvaro
Publicado: (2020)

Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course
por: Muri, Jonathan, et al.
Publicado: (2023)

Immune readouts from the Oxford COVID-19 vaccine
por: Bordon, Yvonne
Publicado: (2021)

Autoantibodies to Chemokines and Cytokines Participate in the Regulation of Cancer and Autoimmunity
por: Karin, Nathan
Publicado: (2018)

Coordinating risk communication and community engagement for a better COVID-19 response in Eastern and Southern Africa
por: Kakaire, Charles Nelson, et al.
Publicado: (2022)

CC Chemokine Receptor (CCR)4 and the CCR10 Ligand Cutaneous T Cell–attracting Chemokine (CTACK) in Lymphocyte Trafficking to Inflamed Skin
por: Reiss, Yvonne, et al.
Publicado: (2001)

Inhaled nanobodies against COVID-19
por: Martinez-Delgado, Gustavo
Publicado: (2020)

Are adipokines the missing link between obesity, immune response, and outcomes in severe COVID-19?
por: Blot, Mathieu, et al.
Publicado: (2021)

Distinct serum and cerebrospinal fluid cytokine and chemokine profiles in autoantibody-associated demyelinating diseases
por: Hofer, Livia S, et al.
Publicado: (2019)

Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages
por: Bohnacker, Sina, et al.
Publicado: (2022)

Maternal Immune Dysregulation and Autism–Understanding the Role of Cytokines, Chemokines and Autoantibodies
por: McLellan, Janna, et al.
Publicado: (2022)

Tropomyosin autoantibodies associated with checkpoint inhibitor myositis
por: Zaenker, Pauline, et al.
Publicado: (2020)

Class A scavenger receptors regulate tolerance against apoptotic cells, and autoantibodies against these receptors are predictive of systemic lupus
por: Wermeling, Fredrik, et al.
Publicado: (2007)

Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1
por: Bastard, Paul, et al.
Publicado: (2021)

Temporal Dynamics of Anti–Type 1 Interferon Autoantibodies in Patients With Coronavirus Disease 2019
por: Shaw, Elana R, et al.
Publicado: (2021)

Anti–SARS-CoV-2 and Autoantibody Profiles in the Cerebrospinal Fluid of 3 Teenaged Patients With COVID-19 and Subacute Neuropsychiatric Symptoms
por: Bartley, Christopher M., et al.
Publicado: (2021)

COVID-19 trial graph: a linked graph for COVID-19 clinical trials
por: Du, Jingcheng, et al.
Publicado: (2021)

Chemokines and chemokine receptors during COVID-19 infection
por: Khalil, Bariaa A., et al.
Publicado: (2021)

Differential Chemokine Signature between Human Preadipocytes and Adipocytes
por: Ignacio, Rosa Mistica C., et al.
Publicado: (2016)

Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing
por: Sechi, Elia, et al.
Publicado: (2021)

Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis
por: Sabbagh, Sara E., et al.
Publicado: (2021)

Aberrant Chemokine Receptor Expression and Chemokine Production by Langerhans Cells Underlies the Pathogenesis of Langerhans Cell Histiocytosis
por: Annels, Nicola E., et al.
Publicado: (2003)

Tumor-associated autoantibodies correlate with poor outcome in prostate cancer patients treated with androgen deprivation and external beam radiation therapy
por: Johnson, Lisa DS, et al.
Publicado: (2014)

Targeting autoantibodies in COVID-19
por: Pedroza-Pacheco, Isabela, et al.
Publicado: (2021)

Evidence for preferential attachment: Words that are more well connected in semantic networks are better at acquiring new links in paired-associate learning
por: Mak, Matthew H. C., et al.
Publicado: (2020)

Increased TLR/MyD88 signaling in patients with obesity: is there a link to COVID-19 disease severity?
por: Cuevas, Ada M., et al.
Publicado: (2021)

The CSF Levels of Neutrophil‐Related Chemokines in Patients with Neuromyelitis Optica
por: Liu, Zhuhe, et al.
Publicado: (2020)

Prevalence of thyroid function test abnormalities and thyroid autoantibodies in children with vitiligo
por: Afsar, Fatma Sule, et al.
Publicado: (2013)

Autoantibody-Mediated Dysfunction of Salivary Glands Leads to Xerostomia in SKG Mice
por: Choi, Suk San, et al.
Publicado: (2019)

Persistent expression of autoantibodies in SLE patients in remission
por: Yurasov, Sergey, et al.
Publicado: (2006)

National Early Warning Score 2 (NEWS2) better predicts critical Coronavirus Disease 2019 (COVID-19) illness than COVID-GRAM, a multi-centre study
por: De Socio, Giuseppe Vittorio, et al.
Publicado: (2021)

Autoantibodies against type I IFNs in patients with life-threatening COVID-19
por: Bastard, Paul, et al.
Publicado: (2020)

Autoantibodies against Angiotensin-converting enzyme 2 and immune molecules are associated with COVID-19 disease severity
por: Bradley, Todd, et al.
Publicado: (2023)

Innate immune cell genetic risk factors are linked to COVID-19 severity
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q5m0v7rj8vqu6q7sp6o31071ip